Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rFVIIa for Acute ICH in Patients on Antithrombotics
NCT00222625Phase 2Unknown
- Sponsor
- University of Perugia
- Start
- Sep 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of coagulation factor VIIa in intracerebral hemorrhage (ICH) (2 arms), sponsored by University of Perugia. Primary endpoint: Change in Intracerebral Hemorrhage Volume at 24 hours. Status: unknown.
02
Drugs
coagulation factor VIIa
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT00222625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00222625.